Drug Resistance in Leishmaniasis

@inproceedings{Chakravarty2010DrugRI,
  title={Drug Resistance in Leishmaniasis},
  author={Jaya Chakravarty and Shyam Sundar},
  booktitle={Journal of global infectious diseases},
  year={2010}
}
The treatment options of leishmaniasis are limited and far from satisfactory. For more than 60 years, treatment of leishmaniasis has centered around pentavalent antimonials (Sb(v)). Widespread misuse has led to the emergence of Sb(v) resistance in the hyperendemic areas of North Bihar. Other antileishmanials could also face the same fate, especially in the anthroponotic cycle. The HIV/ visceral leishmaniasis (VL) coinfected patients are another potential source for the emergence of drug… CONTINUE READING
Highly Influential
This paper has highly influenced 31 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 526 extracted citations

Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Antimicrobial agents and chemotherapy • 2012
View 12 Excerpts
Highly Influenced

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs

International journal for parasitology. Drugs and drug resistance • 2018
View 9 Excerpts
Highly Influenced

Proteomic approaches for drug discovery against tegumentary leishmaniasis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie • 2017
View 5 Excerpts
Highly Influenced

Screening and evaluation of antiparasitic and in vitro anticancer activities of Panamanian endophytic fungi.

International microbiology : the official journal of the Spanish Society for Microbiology • 2011
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…